Header Logo

Christopher Seder

Concepts (363)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
35
2022
546
9.180
Why?
Carcinoma, Non-Small-Cell Lung
15
2021
240
5.530
Why?
Pneumonectomy
20
2022
77
5.310
Why?
Thoracic Surgery
14
2022
27
4.930
Why?
Esophageal Neoplasms
8
2022
53
3.720
Why?
Databases, Factual
13
2021
315
2.330
Why?
Societies, Medical
11
2020
144
2.120
Why?
Adenocarcinoma
8
2018
139
2.090
Why?
Thoracic Surgical Procedures
5
2019
9
1.800
Why?
Neoplasm Staging
13
2021
358
1.730
Why?
Humans
74
2023
26260
1.560
Why?
Postoperative Complications
8
2022
825
1.430
Why?
Thoracic Wall
3
2016
12
1.410
Why?
Quality Improvement
4
2019
140
1.340
Why?
Thoracic Surgery, Video-Assisted
7
2021
20
1.150
Why?
Neoplasm Recurrence, Local
3
2017
193
1.130
Why?
Biomarkers, Tumor
7
2022
199
1.100
Why?
Aged
33
2021
8595
1.070
Why?
Lung
5
2022
148
1.060
Why?
Neoplasms, Multiple Primary
2
2015
39
0.980
Why?
Female
39
2022
14520
0.950
Why?
Male
41
2022
14168
0.920
Why?
Cardiac Surgical Procedures
2
2016
33
0.880
Why?
Laparoscopy
3
2022
144
0.860
Why?
Colonic Neoplasms
3
2017
57
0.830
Why?
Robotics
2
2013
17
0.820
Why?
Biology
1
2022
8
0.810
Why?
Phosphoproteins
1
2022
27
0.810
Why?
Middle Aged
28
2022
8541
0.800
Why?
Carcinoma, Adenoid Cystic
1
2022
3
0.790
Why?
Registries
2
2021
170
0.760
Why?
Retrospective Studies
18
2022
3283
0.750
Why?
Robotic Surgical Procedures
1
2021
28
0.730
Why?
Advisory Committees
2
2018
25
0.720
Why?
Surgical Oncology
1
2020
6
0.710
Why?
Prognosis
9
2022
710
0.700
Why?
Checklist
1
2020
25
0.690
Why?
Lymphadenopathy
1
2020
1
0.690
Why?
Combined Modality Therapy
5
2020
294
0.670
Why?
Gases
1
2019
5
0.660
Why?
Intubation, Gastrointestinal
2
2010
11
0.650
Why?
Hate
1
2019
2
0.650
Why?
Chest Tubes
1
2019
3
0.650
Why?
Carcinoma, Squamous Cell
4
2019
172
0.650
Why?
Thoracotomy
3
2021
25
0.650
Why?
Inhibin-beta Subunits
2
2009
2
0.640
Why?
Catheter Ablation
1
2020
61
0.640
Why?
Clostridium Infections
2
2009
22
0.630
Why?
Enteral Nutrition
2
2010
59
0.630
Why?
Aged, 80 and over
15
2018
4594
0.620
Why?
Heart Diseases
2
2016
62
0.600
Why?
Diaphragm
1
2018
7
0.600
Why?
Mucous Membrane
1
2018
28
0.590
Why?
Foreign-Body Migration
1
2018
16
0.590
Why?
Scoliosis
1
2018
17
0.590
Why?
Risk Assessment
5
2019
592
0.580
Why?
Adult
16
2018
7516
0.570
Why?
Internationality
1
2017
23
0.560
Why?
Prosthesis Failure
2
2018
533
0.560
Why?
Databases as Topic
1
2017
15
0.560
Why?
Quality Assurance, Health Care
1
2017
36
0.550
Why?
Benchmarking
1
2017
35
0.550
Why?
Cardiology
1
2016
42
0.520
Why?
Ribs
1
2016
13
0.520
Why?
Hypoglycemic Agents
1
2016
35
0.510
Why?
Metformin
1
2016
19
0.510
Why?
Pulmonary Blastoma
1
2015
4
0.510
Why?
Mediastinal Neoplasms
1
2015
10
0.500
Why?
Nurse Practitioners
1
2017
107
0.500
Why?
United States
9
2021
2043
0.500
Why?
Academic Medical Centers
1
2016
124
0.500
Why?
Testicular Neoplasms
1
2015
18
0.500
Why?
Neoplasm Invasiveness
4
2018
89
0.500
Why?
Solitary Pulmonary Nodule
1
2015
15
0.490
Why?
Lung Diseases, Fungal
1
2015
8
0.480
Why?
Early Medical Intervention
1
2015
14
0.480
Why?
Mucormycosis
1
2015
8
0.480
Why?
Treatment Outcome
13
2021
3285
0.480
Why?
Quality of Health Care
1
2016
115
0.470
Why?
Survival Rate
7
2021
315
0.460
Why?
Surgical Mesh
1
2014
20
0.450
Why?
Risk Adjustment
3
2020
10
0.450
Why?
Manubrium
1
2014
2
0.450
Why?
Replantation
1
2014
8
0.450
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
228
0.450
Why?
Herniorrhaphy
1
2014
28
0.450
Why?
Clavicle
1
2014
13
0.440
Why?
Practice Guidelines as Topic
1
2016
294
0.440
Why?
Diabetes Mellitus, Type 2
1
2016
183
0.430
Why?
Esophagectomy
3
2022
23
0.420
Why?
Mitral Valve Annuloplasty
1
2012
1
0.410
Why?
Tricuspid Valve Prolapse
1
2012
2
0.410
Why?
Prostheses and Implants
1
2014
151
0.410
Why?
Heart Valve Prosthesis Implantation
1
2012
18
0.410
Why?
Breast Neoplasms
2
2017
391
0.400
Why?
Surgery, Computer-Assisted
1
2012
47
0.390
Why?
Cell Line, Tumor
4
2022
229
0.380
Why?
Spinal Fusion
1
2018
376
0.370
Why?
Tomography, X-Ray Computed
6
2018
675
0.370
Why?
Survival Analysis
3
2018
242
0.360
Why?
Mitral Valve
1
2010
6
0.350
Why?
Simulation Training
2
2021
40
0.350
Why?
Myxoma
1
2010
4
0.350
Why?
Heart Neoplasms
1
2010
9
0.350
Why?
Neoadjuvant Therapy
3
2022
65
0.340
Why?
Energy Intake
1
2010
80
0.330
Why?
Gene Expression Regulation, Neoplastic
2
2009
106
0.320
Why?
Aneurysm, Infected
1
2009
1
0.320
Why?
Clostridium septicum
1
2009
1
0.320
Why?
Aortitis
1
2009
2
0.320
Why?
Embolism
1
2009
3
0.320
Why?
Embolectomy
1
2009
4
0.320
Why?
Blood Component Transfusion
1
2009
4
0.320
Why?
Length of Stay
4
2016
290
0.320
Why?
Mesenteric Vascular Occlusion
1
2009
4
0.320
Why?
Treatment Refusal
1
2009
10
0.320
Why?
Jehovah's Witnesses
1
2009
3
0.320
Why?
Aortic Aneurysm
1
2009
10
0.320
Why?
Blood Vessel Prosthesis Implantation
3
2018
17
0.320
Why?
Ischemia
1
2009
20
0.320
Why?
Enterocolitis, Pseudomembranous
1
2009
11
0.320
Why?
Religion and Medicine
1
2009
22
0.320
Why?
Intraoperative Complications
1
2009
58
0.310
Why?
Internship and Residency
3
2018
201
0.310
Why?
Bronchoscopy
3
2019
34
0.310
Why?
Risk Factors
4
2022
2221
0.310
Why?
Epigenesis, Genetic
1
2009
85
0.300
Why?
Surgeons
2
2020
84
0.300
Why?
Hospital Costs
1
2008
60
0.300
Why?
Education, Medical, Graduate
2
2020
72
0.290
Why?
Critical Care
1
2010
195
0.290
Why?
Sarcoma
2
2021
142
0.280
Why?
Trachea
2
2022
42
0.270
Why?
Disease-Free Survival
2
2017
163
0.260
Why?
Follow-Up Studies
5
2021
1722
0.260
Why?
Intensive Care Units
1
2008
298
0.260
Why?
Clinical Competence
3
2020
227
0.260
Why?
Early Detection of Cancer
4
2022
103
0.240
Why?
Neovascularization, Pathologic
2
2015
30
0.240
Why?
Biomarkers
2
2017
556
0.240
Why?
Surgical Flaps
2
2015
45
0.230
Why?
Chemoradiotherapy
2
2015
61
0.220
Why?
Embolism, Air
1
2023
10
0.220
Why?
Consensus
2
2021
91
0.220
Why?
Thrombosis
1
2023
48
0.210
Why?
Bronchi
2
2015
11
0.210
Why?
Computer Simulation
2
2021
178
0.210
Why?
Thymoma
2
2020
7
0.210
Why?
Thymus Neoplasms
2
2020
10
0.200
Why?
Blood Coagulation Disorders
1
2022
15
0.200
Why?
Hemostatics
1
2022
12
0.200
Why?
Carbon Monoxide
1
2022
7
0.200
Why?
Intubation, Intratracheal
2
2016
91
0.200
Why?
Cohort Studies
4
2018
1801
0.190
Why?
Lymph Nodes
2
2020
67
0.190
Why?
Programmed Cell Death 1 Receptor
1
2022
16
0.190
Why?
Metastasectomy
1
2021
7
0.190
Why?
Multivariate Analysis
3
2017
296
0.190
Why?
Ventricular Dysfunction, Right
1
2021
7
0.180
Why?
Patient Discharge
1
2022
152
0.180
Why?
Heart-Assist Devices
1
2021
12
0.180
Why?
Incidence
2
2021
709
0.180
Why?
Mediastinal Cyst
1
2020
1
0.170
Why?
Mass Screening
2
2022
174
0.170
Why?
RNA, Messenger
3
2009
290
0.170
Why?
Carcinoma
2
2017
65
0.160
Why?
Smoking
1
2020
164
0.160
Why?
Small Cell Lung Carcinoma
1
2019
9
0.160
Why?
Heart Failure
1
2021
148
0.160
Why?
Ultrasonography, Interventional
1
2020
66
0.160
Why?
False Positive Reactions
1
2019
34
0.160
Why?
Sensitivity and Specificity
4
2018
473
0.160
Why?
Drainage
1
2019
45
0.160
Why?
Insulin-Like Growth Factor I
2
2022
59
0.160
Why?
RNA, Small Interfering
2
2009
70
0.160
Why?
Unnecessary Procedures
1
2019
26
0.160
Why?
Kaplan-Meier Estimate
2
2009
160
0.160
Why?
Thoracoscopy
3
2019
19
0.150
Why?
Obesity
1
2021
299
0.150
Why?
Randomized Controlled Trials as Topic
1
2020
303
0.150
Why?
Aortic Aneurysm, Thoracic
1
2018
7
0.150
Why?
Cell Proliferation
2
2009
171
0.150
Why?
Histocompatibility Antigens Class II
1
2018
6
0.150
Why?
HLA Antigens
1
2018
17
0.150
Why?
Hemoptysis
1
2018
6
0.150
Why?
Radiography, Thoracic
1
2018
24
0.150
Why?
Immunohistochemistry
2
2009
349
0.150
Why?
Multiple Pulmonary Nodules
1
2018
12
0.150
Why?
Syndecan-1
1
2018
4
0.150
Why?
Histocompatibility Antigens Class I
1
2018
18
0.150
Why?
Chest Pain
1
2018
16
0.150
Why?
Diagnosis, Differential
2
2018
343
0.150
Why?
Morbidity
2
2019
49
0.150
Why?
Immunoassay
1
2018
38
0.150
Why?
Nerve Growth Factors
1
2018
37
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
10
0.140
Why?
Bronchial Neoplasms
1
2017
5
0.140
Why?
Minimally Invasive Surgical Procedures
2
2010
186
0.140
Why?
Airway Obstruction
1
2017
20
0.140
Why?
Lymphoma
1
2017
31
0.140
Why?
Suture Techniques
1
2018
155
0.140
Why?
History, 21st Century
1
2016
23
0.140
Why?
Stents
1
2017
76
0.140
Why?
History, 19th Century
1
2016
29
0.140
Why?
History, 20th Century
1
2016
44
0.130
Why?
Diffusion of Innovation
1
2016
29
0.130
Why?
Biopsy
1
2017
202
0.130
Why?
Melanoma
1
2017
57
0.130
Why?
Pneumonia, Bacterial
1
2016
11
0.130
Why?
Adolescent
1
2022
2172
0.130
Why?
Pulmonary Diffusing Capacity
1
2016
9
0.130
Why?
Tracheostomy
1
2016
26
0.130
Why?
Europe
1
2016
57
0.130
Why?
Prospective Studies
1
2021
1665
0.130
Why?
Etoposide
1
2015
24
0.130
Why?
Ifosfamide
1
2015
12
0.130
Why?
Models, Statistical
1
2016
122
0.130
Why?
Cisplatin
1
2015
47
0.120
Why?
Time Factors
1
2019
1347
0.120
Why?
Thymus Gland
1
2015
11
0.120
Why?
Proportional Hazards Models
1
2016
321
0.120
Why?
Diabetes Mellitus
1
2016
127
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
10
0.120
Why?
Comorbidity
1
2016
468
0.120
Why?
Antineoplastic Agents
1
2016
178
0.110
Why?
Thoracic Cavity
1
2014
1
0.110
Why?
Thoracic Neoplasms
1
2014
9
0.110
Why?
Chicago
1
2016
857
0.110
Why?
Mediastinum
1
2013
6
0.110
Why?
Hernia, Hiatal
1
2013
10
0.110
Why?
Fatal Outcome
2
2011
56
0.100
Why?
Tricuspid Valve Insufficiency
1
2012
5
0.100
Why?
Histone Acetyltransferases
2
2009
3
0.100
Why?
Acetylation
2
2009
14
0.100
Why?
Histone Deacetylases
2
2009
11
0.100
Why?
Dyspnea
1
2012
39
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2009
57
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
134
0.100
Why?
Age Factors
2
2016
744
0.100
Why?
Fistula
1
2011
2
0.090
Why?
Gastric Fistula
1
2011
5
0.090
Why?
Anastomotic Leak
1
2011
5
0.090
Why?
Lung Transplantation
1
2011
13
0.090
Why?
Living Donors
1
2011
16
0.090
Why?
Continuous Positive Airway Pressure
1
2011
19
0.090
Why?
Tissue and Organ Procurement
1
2011
33
0.090
Why?
Postoperative Hemorrhage
1
2011
24
0.090
Why?
Graft Rejection
1
2011
62
0.090
Why?
Sutures
1
2011
49
0.090
Why?
Endoleak
1
2010
1
0.090
Why?
Aortic Aneurysm, Abdominal
1
2010
3
0.090
Why?
Chordae Tendineae
1
2010
1
0.090
Why?
Blood Vessel Prosthesis
1
2010
11
0.090
Why?
Blood Pressure Determination
1
2010
16
0.090
Why?
Monitoring, Intraoperative
1
2010
29
0.090
Why?
Surgical Tape
1
2010
3
0.090
Why?
Conscious Sedation
1
2010
5
0.090
Why?
Glasgow Coma Scale
1
2010
8
0.090
Why?
APACHE
1
2010
31
0.090
Why?
Endovascular Procedures
1
2010
31
0.090
Why?
Equipment Failure
1
2010
36
0.080
Why?
Heart Ventricles
1
2010
90
0.080
Why?
Gastric Bypass
1
2011
69
0.080
Why?
Activins
1
2009
1
0.080
Why?
Follistatin
1
2009
1
0.080
Why?
Mesenteric Artery, Superior
1
2009
3
0.080
Why?
Tissue Array Analysis
1
2009
7
0.080
Why?
Probability
1
2009
86
0.080
Why?
Iliac Artery
1
2009
5
0.080
Why?
Blood Pressure
1
2010
197
0.080
Why?
Statistics, Nonparametric
1
2009
122
0.080
Why?
Aorta
1
2009
14
0.080
Why?
Digestive System Surgical Procedures
1
2009
22
0.080
Why?
Multiple Organ Failure
1
2009
21
0.080
Why?
Histones
1
2009
26
0.080
Why?
Cattle
1
2009
120
0.080
Why?
Transfection
1
2009
111
0.080
Why?
Blotting, Western
1
2009
144
0.080
Why?
Promoter Regions, Genetic
1
2009
93
0.080
Why?
Histone Deacetylase Inhibitors
1
2008
8
0.080
Why?
Safety
1
2008
40
0.080
Why?
Debridement
1
2009
100
0.080
Why?
Glycoproteins
1
2008
44
0.080
Why?
Cost-Benefit Analysis
1
2008
122
0.080
Why?
Acute Disease
1
2009
190
0.080
Why?
Enzyme Inhibitors
1
2008
114
0.080
Why?
Anticoagulants
1
2009
84
0.070
Why?
Recurrence
1
2009
288
0.070
Why?
Carrier Proteins
1
2008
103
0.070
Why?
Up-Regulation
1
2009
166
0.070
Why?
Autoantibodies
1
2008
78
0.070
Why?
DNA Methylation
1
2009
161
0.070
Why?
Anti-Bacterial Agents
1
2009
362
0.060
Why?
Magnetic Resonance Imaging
1
2010
1069
0.060
Why?
Reproducibility of Results
2
2019
683
0.060
Why?
Iatrogenic Disease
1
2023
25
0.050
Why?
Thrombelastography
1
2022
5
0.050
Why?
Blood Coagulation Tests
1
2022
11
0.050
Why?
Hemostasis
1
2022
8
0.050
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.050
Why?
Hemorrhage
1
2022
76
0.050
Why?
Tumor Microenvironment
1
2022
16
0.050
Why?
Inflammation
1
2023
264
0.050
Why?
Predictive Value of Tests
2
2014
422
0.050
Why?
Animals
1
2009
3551
0.050
Why?
Equipment Design
2
2011
134
0.040
Why?
Young Adult
2
2017
1948
0.040
Why?
Mediastinoscopy
1
2019
7
0.040
Why?
Hemolysis
1
2018
5
0.040
Why?
North America
1
2018
32
0.040
Why?
Magnetic Resonance Angiography
1
2018
29
0.040
Why?
Canada
1
2018
49
0.040
Why?
Pneumonia
1
2019
72
0.040
Why?
Carcinoma, Embryonal
1
2017
3
0.040
Why?
Dilatation
1
2017
9
0.040
Why?
Tonsillar Neoplasms
1
2017
3
0.040
Why?
Leiomyosarcoma
1
2017
19
0.030
Why?
Carcinoma, Renal Cell
1
2017
41
0.030
Why?
Propensity Score
1
2016
28
0.030
Why?
Kidney Neoplasms
1
2017
66
0.030
Why?
Skin Neoplasms
1
2017
67
0.030
Why?
Neoplasm, Residual
1
2015
6
0.030
Why?
Practice Patterns, Physicians'
1
2016
112
0.030
Why?
Lymph Node Excision
1
2015
23
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
16
0.030
Why?
Radiotherapy Dosage
1
2015
116
0.030
Why?
Minnesota
1
2014
9
0.030
Why?
Sex Factors
1
2016
456
0.030
Why?
Area Under Curve
1
2014
58
0.030
Why?
Postoperative Period
1
2016
326
0.030
Why?
Analysis of Variance
1
2015
259
0.030
Why?
ROC Curve
1
2014
133
0.030
Why?
Illinois
1
2014
223
0.030
Why?
Patient Readmission
1
2015
127
0.030
Why?
Cytokines
1
2014
224
0.030
Why?
Disease Progression
1
2014
676
0.020
Why?
Algorithms
1
2014
357
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
4
0.020
Why?
Esophageal Perforation
1
2011
8
0.020
Why?
Proton Pump Inhibitors
1
2011
13
0.020
Why?
Candidiasis
1
2011
19
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
18
0.020
Why?
Pulmonary Gas Exchange
1
2011
5
0.020
Why?
Surgical Stapling
1
2011
4
0.020
Why?
Constriction, Pathologic
1
2011
30
0.020
Why?
Graft Survival
1
2011
96
0.020
Why?
Transducers, Pressure
1
2010
4
0.020
Why?
Aortography
1
2010
6
0.020
Why?
Respiration, Artificial
1
2011
111
0.020
Why?
Rupture
1
2010
111
0.020
Why?
Obesity, Morbid
1
2011
95
0.020
Why?
Hydroxamic Acids
1
2008
5
0.020
Why?
Immunoenzyme Techniques
1
2008
28
0.020
Why?
Adipokines
1
2008
6
0.020
Why?
Azacitidine
1
2008
10
0.020
Why?
Tumor Cells, Cultured
1
2008
115
0.020
Why?
Gene Expression Profiling
1
2008
136
0.020
Why?
Reoperation
1
2011
888
0.020
Why?
Case-Control Studies
1
2008
567
0.020
Why?
Seder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_